×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Michael J. Labarre

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerJul 15, 2021Option/RSU Exercise$6.5514,68596,187148,796Jul 15, 2021, 07:36 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerJul 01, 2021Option/RSU Exercise$6.5540,315264,063174,426Jul 06, 2021, 05:19 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerJul 01, 2021Sale$45.7040,3151,842,315134,111Jul 06, 2021, 05:19 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerMay 03, 2021Option/RSU Exercise$11.2911,311127,701134,111May 03, 2021, 08:27 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerApr 01, 2021Option/RSU Exercise$11.2928,689323,899151,489Apr 01, 2021, 07:44 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerApr 01, 2021Sale$42.5628,6891,221,037141,794Apr 01, 2021, 07:44 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerMar 01, 2021Sale$45.8118,324839,364129,330Mar 01, 2021, 08:06 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 22, 2021Option/RSU Exercise-8,803-145,488Feb 22, 2021, 06:28 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 22, 2021Tax Payment (Shares)$48.694,364212,483141,124Feb 22, 2021, 06:28 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 14, 2021Tax Payment (Shares)$49.842,272113,236136,685Feb 16, 2021, 04:56 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 14, 2021Option/RSU Exercise-5,771-138,957Feb 16, 2021, 04:56 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 10, 2021Option/RSU Exercise-8,134-130,934Feb 12, 2021, 07:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 12, 2021Tax Payment (Shares)$49.842,725135,814133,186Feb 12, 2021, 07:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 12, 2021Option/RSU Exercise-7,883-135,911Feb 12, 2021, 07:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 10, 2021Tax Payment (Shares)$50.602,906147,044128,028Feb 12, 2021, 07:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerDec 21, 2020Sale$42.5812,000510,919123,400Dec 21, 2020, 06:01 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerNov 20, 2020Sale$38.7612,000465,176142,689Nov 20, 2020, 06:25 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerOct 20, 2020Sale$30.4312,000365,148146,800Oct 20, 2020, 04:53 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerSep 21, 2020Sale$26.9112,000322,884158,800Sep 21, 2020, 07:30 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerAug 20, 2020Sale$28.3012,000339,564170,800Aug 20, 2020, 04:21 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerJul 20, 2020Sale$29.0112,000348,072182,800Jul 20, 2020, 06:33 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerMay 22, 2020Option/RSU Exercise$7.1418,613132,897194,800May 22, 2020, 06:39 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerMay 20, 2020Option/RSU Exercise$7.1421,387152,703197,574May 21, 2020, 04:11 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerMay 20, 2020Sale$23.8021,387509,075176,187May 21, 2020, 04:11 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 22, 2020Tax Payment (Shares)$21.833,04466,451176,187Feb 24, 2020, 08:04 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 22, 2020Option/RSU Exercise-8,803-179,231Feb 24, 2020, 08:04 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 14, 2020Tax Payment (Shares)$21.101,99542,095170,428Feb 18, 2020, 04:16 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 14, 2020Option/RSU Exercise-5,772-172,423Feb 18, 2020, 04:16 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 12, 2020Tax Payment (Shares)$20.002,72554,500166,651Feb 13, 2020, 06:39 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 12, 2020Option/RSU Exercise-7,883-169,376Feb 13, 2020, 06:39 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 03, 2020Tax Payment (Shares)$19.214,28982,392161,493Feb 04, 2020, 04:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 03, 2020Option/RSU Exercise-11,559-165,782Feb 04, 2020, 04:24 PM